A better method to predict polygenic inheritance across multiple ancestries

FHS
October 2, 2023
11:53 am

Researchers report the results obtained from the use of a new PRS calculator called CT-SLEB on a multi-national GWAS database.

DDX41: A unique player in myeloid leukemogenesis

A new editorial paper was published in Oncotarget’s Volume 15 on July 2, 2024, entitled, “DDX41 and its unique contribution to myeloid leukemogenesis.”

July 20, 2024

Study offers insights into who’s at risk for long COVID among immunocompromised patients

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.

January 27, 2024

To get a fair deal on Wegovy, buying Novo Nordisk might not be Medicare’s worst option

Medicare and Medicaid are facing a familiar quandary: how to provide coverage for new weight loss drugs with price tags that could effectively bankrupt the

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.